Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
BASAGLAR (insulin glargine) is long-acting insulin prescribed to regulate blood sugar in patients with diabetes mellitus.
Patients with diabetes have blood sugar levels that are too high or too low. BASAGLAR insulin helps to regulate these levels and keep blood sugar in a normal range.
Inject BASAGLAR under the skin once daily at the same time each day.
The prescribing physician will determine the dose of BASAGLAR.
Do not mix BASAGLAR with other types of insulin in the same syringe.
Once opened, BASAGLAR vials or pens should be stored at room temperature for up to 28 days.
The active ingredient in BASAGLAR is insulin glargine.
Some medications can raise or lower blood sugar, which can change the amount of insulin required to bring blood sugar into a normal range. Some of these medications may include:
Hypoglycemia (low blood sugar) is a severe and sometimes life-threatening side effect of insulin use. It is essential to be aware of the symptoms of hypoglycemia so it can be treated early. These medications may mask the symptoms and make it harder to detect:
Do not share insulin pens with other patients, even if the pen needle is changed between each injection.
Monitor blood sugar closely when making any changes to the insulin regimen, including adding or removing meal-time insulin, changing administration sites, changing manufacturers, or changing the time of administration.
Examine the label carefully before each BASAGLAR injection to lower the risk of medication errors.
Common side effects that can happen with BASAGLAR may include:
Basaglar [package insert] Indianapolis, IN: Lilly; 2019.